On the public citation graph
Vaccine Development to Prevent Cytomegalovirus Disease: Report from the National Vaccine Advisory Committee
0 signed · 367 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1001/jama.289.8.1008openalex-snapshot
Maternal Immunity and Prevention of Congenital Cytomegalovirus Infection
inferredcites →https://doi.org/10.1002/1521-4141(200006)30:6<1676::aid-immu1676>3.0.co;2-vopenalex-snapshot
Analysis of CD8 T cell reactivity to cytomegalovirus using protein-spanning pools of overlapping pentadecapeptides
inferredcites →https://doi.org/10.1006/viro.2002.1661openalex-snapshot
Transmission of Human Cytomegalovirus from Infected Uterine Microvascular Endothelial Cells to Differentiating/Invasive Placental Cytotrophoblasts
inferredcites →https://doi.org/10.1016/s0002-8703(99)70281-4openalex-snapshot
Cytomegalovirus vaccine
inferredcites →https://doi.org/10.1016/s0022-3476(05)80859-5openalex-snapshot
Congenital cytomegalovirus infection and neonatal auditory screening
inferredcites →https://doi.org/10.1016/s0022-3476(81)80662-2openalex-snapshot
Prevention of transfusion-acquired cytomegalovirus infections in newborn infants
inferredcites →https://doi.org/10.1016/s0966-842x(02)02393-4openalex-snapshot
Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion
inferredcites →https://doi.org/10.1016/s1386-6532(02)00099-9openalex-snapshot
Development of novel vaccine strategies against human cytomegalovirus infection based on subviral particles
inferredcites →https://doi.org/10.1016/s1386-6532(02)00100-2openalex-snapshot
Animal models of congenital cytomegalovirus infection: an overview of progress in the characterization of guinea pig cytomegalovirus (GPCMV)
inferredcites →https://doi.org/10.1038/nri932openalex-snapshot
Antigens and immunoevasins: opponents in cytomegalovirus immune surveillance
inferredcites →https://doi.org/10.1056/nejm198911093211903openalex-snapshot
Cytomegalovirus and Child Day Care
inferredcites →https://doi.org/10.1056/nejm199203053261003openalex-snapshot
The Outcome of Congenital Cytomegalovirus Infection in Relation to Maternal Antibody Status
inferredcites →https://doi.org/10.1056/nejm199510193331603openalex-snapshot
Reconstitution of Cellular Immunity against Cytomegalovirus in Recipients of Allogeneic Bone Marrow by Transfer of T-Cell Clones from the Donor
inferredcites →https://doi.org/10.1086/314939openalex-snapshot
Asymptomatic Primary Cytomegalovirus Infection: Virologic and Immunologic Features
inferredcites →https://doi.org/10.1086/315022openalex-snapshot
A Subunit Cytomegalovirus Vaccine Based on Recombinant Envelope Glycoprotein B and a New Adjuvant
inferredcites →https://doi.org/10.1086/315060openalex-snapshot
Effects of Antigen Dose and Immunization Regimens on Antibody Responses to a Cytomegalovirus Glycoprotein B Subunit Vaccine
inferredcites →https://doi.org/10.1086/315445openalex-snapshot
Cytotoxic T Lymphocyte (CTL) Responses to Human Cytomegalovirus pp65, IE1‐Exon4, gB, pp150, and pp28 in Healthy Individuals: Reevaluation of Prevalence of IE1‐Specific CTLs
inferredcites →https://doi.org/10.1086/339003openalex-snapshot
Effect of Previous or Simultaneous Immunization with Canarypox Expressing Cytomegalovirus (CMV) Glycoprotein B (gB) on Response to Subunit gB Vaccine plus MF59 in Healthy CMV‐Seronegative Adults
inferredcites →https://doi.org/10.1086/340637openalex-snapshot
Cytomegalovirus (CMV) Phosphoprotein 65 Makes a Large Contribution to Shaping the T Cell Repertoire in CMV‐Exposed Individuals
inferredcites →https://doi.org/10.1086/379839openalex-snapshot
Preconception Vaccination with a Glycoprotein B (gB) DNA Vaccine Protects against Cytomegalovirus (CMV) Transmission in the Guinea Pig Model of Congenital CMV Infection
inferredcites →https://doi.org/10.1089/08828240050144653openalex-snapshot
Antibodies to the Major Linear Neutralizing Domains of Cytomegalovirus Glycoprotein B Among Natural Seropositives and CMV Subunit Vaccine Recipients
inferredcites →https://doi.org/10.1089/hum.1992.3.3-319openalex-snapshot
Phase I Study of Cellular Adoptive Immunotherapy Using Genetically Modified CD8 + HIV-Specific T Cells for HIV Seropositive Patients Undergoing Allogeneic Bone Marrow Transplant. Fred Hutchinson Cancer Research Center and the University of Washington
inferredcites →https://doi.org/10.1093/clinids/12.5.745openalex-snapshot
Acute Respiratory Disease in Spain: Seven Years of Experience
inferredcites →https://doi.org/10.1093/clinids/12.supplement_7.s745openalex-snapshot
Congenital and Perinatal Cytomegalovirus Infections
inferredcites →https://doi.org/10.1093/clinids/20.3.665openalex-snapshot
Surveillance for Congenital Cytomegalovirus Disease: A Report from the National Congenital Cytomegalovirus Disease Registry
inferredcites →https://doi.org/10.1093/clinids/8.4.599openalex-snapshot
Group Day Care and Cytomegaloviral Infections of Mothers and Children
inferredcites →https://doi.org/10.1093/infdis/174.2.387openalex-snapshot
Mucosal Antibodies to Human Cytomegalovirus Glycoprotein B Occur following both Natural Infection and Immunization with Human Cytomegalovirus Vaccines
inferredcites →https://doi.org/10.1097/00006454-200202000-00009openalex-snapshot
Immunogenicity of a recombinant human cytomegalovirus gB vaccine in seronegative toddlers
inferredcites →https://doi.org/10.1111/j.1399-0012.1994.tb00935.xopenalex-snapshot
Use of immune globulin to prevent symptomatic cytomegalovirus disease in transplant recipients ‐ A meta‐analysis
inferredcites →https://doi.org/10.1126/science.1352912openalex-snapshot
Restoration of Viral Immunity in Immunodeficient Humans by the Adoptive Transfer of T Cell Clones
inferredcites →https://doi.org/10.1126/science.280.5361.248openalex-snapshot
Viral Strategies of Immune Evasion
inferredcites →https://doi.org/10.1128/cmr.11.3.533openalex-snapshot
Quantitation of Cytomegalovirus: Methodologic Aspects and Clinical Applications
inferredcites →https://doi.org/10.1128/cmr.15.4.680-715.2002openalex-snapshot
Diagnosis and Management of Human Cytomegalovirus Infection in the Mother, Fetus, and Newborn Infant
inferredcites →https://doi.org/10.1128/jvi.70.11.7569-7579.1996openalex-snapshot
The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL
inferredcites →https://doi.org/10.1128/jvi.70.3.2044-2048.1996openalex-snapshot
Defined large-scale alterations of the human cytomegalovirus genome constructed by cotransfection of overlapping cosmids
inferredcites →https://doi.org/10.1128/jvi.74.15.6808-6820.2000openalex-snapshot
Human Cytomegalovirus Infection of Placental Cytotrophoblasts In Vitro and In Utero: Implications for Transmission and Pathogenesis
inferredcites →https://doi.org/10.1146/annurev.immunol.13.1.545openalex-snapshot
Principles for Adoptive T Cell Therapy of Human Viral Diseases
inferredcites →https://doi.org/10.1146/annurev.immunol.18.1.861openalex-snapshot
Viral Subversion of the Immune System
inferredcites →https://doi.org/10.1159/000150510openalex-snapshot
Human Cytomegalovirus Glycoproteins
inferredcites →https://doi.org/10.1172/jci119338openalex-snapshot
Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency.
inferredcites →https://doi.org/10.1182/blood.v90.5.1751openalex-snapshot
Development of a Candidate HLA A*0201 Restricted Peptide-Based Vaccine Against Human Cytomegalovirus Infection
inferredcites →https://doi.org/10.1517/14712598.1.3.401openalex-snapshot
Development of a cytomegalovirus vaccine: lessons from recent clinical trials
inferredcites →https://doi.org/10.7326/0003-4819-114-7-525openalex-snapshot
Effect of Towne Live Virus Vaccine on Cytomegalovirus Disease after Renal Transplant
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.3800383openalex-extracted
Novel Potent Neutralizing Antibodies Revealed the Domain I of HCMV Glycoprotein B for Vaccine Design
inferred← citeshttps://doi.org/10.1001/archoto.2009.210openalex-snapshot
Development of Cytomegalovirus-Mediated Sensorineural Hearing Loss in a Guinea Pig Model
inferred← citeshttps://doi.org/10.1002/9780470015902.a0001017.pub2openalex-snapshot
Cytomegaloviruses
inferred← citeshttps://doi.org/10.1002/9780470015902.a0001017.pub3openalex-snapshot
Cytomegaloviruses
inferred← citeshttps://doi.org/10.1002/bdra.23601openalex-snapshot
Cytomegalovirus infection in pregnancy
inferred← citeshttps://doi.org/10.1002/jmv.23273openalex-snapshot
Role of mutations identified in ORFs M27, M36, m139, m141, and m143 in the temperature‐sensitive phenotype of murine cytomegalovirus mutant tsm5
inferred← citeshttps://doi.org/10.1002/lary.24090openalex-snapshot
A Comparison of Different Murine Models for Cytomegalovirus‐Induced Sensorineural Hearing Loss
inferred← citeshttps://doi.org/10.1002/pd.2013openalex-snapshot
Regression of fetal cerebral abnormalities by primary cytomegalovirus infection following hyperimmunoglobulin therapy
inferred← citeshttps://doi.org/10.1002/rmv.1797openalex-snapshot
Human cytomegalovirus tropism for mucosal myeloid dendritic cells
inferred← citeshttps://doi.org/10.1002/rmv.1814openalex-snapshot
Prevention of congenital cytomegalovirus complications by maternal and neonatal treatments: a systematic review
inferred← citeshttps://doi.org/10.1002/rmv.1986openalex-snapshot
Cytomegalovirus vaccine: timing is important
inferred← citeshttps://doi.org/10.1002/rmv.2034openalex-snapshot
Estimation of the worldwide seroprevalence of cytomegalovirus: A systematic review and meta‐analysis
inferred← citeshttps://doi.org/10.1002/rmv.535openalex-snapshot
Review and meta‐analysis of the epidemiology of congenital cytomegalovirus (CMV) infection
inferred← citeshttps://doi.org/10.1002/rmv.616openalex-snapshot
The beginning of the end of a long wait for a vaccine against cytomegalovirus
inferred← citeshttps://doi.org/10.1007/978-1-4939-1071-7_14openalex-snapshot
Congenital Cytomegalovirus Disease
inferred← citeshttps://doi.org/10.1007/978-1-60761-644-3_30openalex-snapshot
Cytomegalovirus in Patients with Cancer
inferred← citeshttps://doi.org/10.1007/978-3-0346-0219-8_6openalex-snapshot
CMV Subversion of the Immune System in Later Life
inferred← citeshttps://doi.org/10.1007/978-3-319-28797-3_24openalex-snapshot
Cytomegalovirus Infection After Stem Cell Transplantation
inferred← citeshttps://doi.org/10.1007/978-3-540-77349-8_20openalex-snapshot
Cytomegalovirus Vaccine Development
inferred← citeshttps://doi.org/10.1007/978-981-10-7230-7_13openalex-snapshot
Vaccine Development for Cytomegalovirus
inferred← citeshttps://doi.org/10.1007/s00281-014-0449-1openalex-snapshot
Models of vertical cytomegalovirus (CMV) transmission and pathogenesis
inferred← citeshttps://doi.org/10.1007/s00430-007-0066-xopenalex-snapshot
The history of cytomegalovirus and its diseases
inferred← citeshttps://doi.org/10.1007/s00430-008-0095-0openalex-snapshot
Polyclonal cytomegalovirus-specific antibodies not only prevent virus dissemination from the portal of entry but also inhibit focal virus spread within target tissues
inferred← citeshttps://doi.org/10.1007/s00430-009-0112-yopenalex-snapshot
Diagnostic value of HCMV pp65 antigen detection by FCA for symptomatic and asymptomatic infection: compared to quantification of HCMV DNA and detection of IgM antibody in infants
inferred← citeshttps://doi.org/10.1007/s00430-016-0472-zopenalex-snapshot
Prospects of a vaccine for the prevention of congenital cytomegalovirus disease
inferred← citeshttps://doi.org/10.1007/s10995-006-0092-0openalex-snapshot
Toxoplasmosis, Cytomegalovirus, Listeriosis, and Preconception Care
inferred← citeshttps://doi.org/10.1007/s11262-017-1452-0openalex-snapshot
Genomic analysis of chimeric human cytomegalovirus vaccine candidates derived from strains Towne and Toledo
inferred← citeshttps://doi.org/10.1007/s11899-020-00557-6openalex-snapshot
Moving Past Ganciclovir and Foscarnet: Advances in CMV Therapy
inferred← citeshttps://doi.org/10.1007/s12033-007-9029-0openalex-snapshot
Sustained Expression of Human Cytomegalovirus Glycoprotein B (UL55) in the Seeds of Homozygous Rice Plants
inferred← citeshttps://doi.org/10.1007/s12250-013-3330-9openalex-snapshot
Immunization with cytomegalovirus envelope glycoprotein M and glycoprotein N DNA vaccines can provide mice with complete protection against a lethal murine cytomegalovirus challenge
inferred← citeshttps://doi.org/10.1016/b978-0-12-811924-2.00044-4openalex-snapshot
Maternal Vaccination for Protection Against Maternal and Infant Bacterial and Viral Pathogens
inferred← citeshttps://doi.org/10.1016/b978-0-323-35761-6.00016-xopenalex-snapshot
Cytomegalovirus Vaccines
inferred← citeshttps://doi.org/10.1016/b978-0-323-69618-0.00012-3openalex-snapshot
Early Detection and Diagnosis of Infant Hearing Impairment
inferred← citeshttps://doi.org/10.1016/b978-0-323-79058-1.00018-9openalex-snapshot
Cytomegalovirus Vaccines
inferred← citeshttps://doi.org/10.1016/b978-1-4160-2450-7.50254-1openalex-snapshot
10.1016/b978-1-4160-2450-7.50254-1
inferred← citeshttps://doi.org/10.1016/b978-1-4160-4044-6.50078-9openalex-snapshot
VIRAL INFECTIONS OF THE FETUS AND NEONATE
inferred← citeshttps://doi.org/10.1016/b978-1-4557-0090-5.00046-xopenalex-snapshot
Cytomegalovirus vaccines
inferred← citeshttps://doi.org/10.1016/b978-2-294-70962-3.00031-8openalex-snapshot
Cytomégalovirus et grossesse
inferred← citeshttps://doi.org/10.1016/b978-84-8086-390-2.50013-9openalex-snapshot
Infecciones víricas
inferred← citeshttps://doi.org/10.1016/bs.adgen.2014.10.005openalex-snapshot
Self-Amplifying mRNA Vaccines
inferred← citeshttps://doi.org/10.1016/j.acpath.2022.100020openalex-snapshot
Educational Case: Infections during pregnancy: Congenital cytomegalovirus infection
inferred← citeshttps://doi.org/10.1016/j.ajhg.2025.02.007openalex-snapshot
Human leukocyte antigen variation is associated with cytomegalovirus serostatus in healthy individuals
inferred← citeshttps://doi.org/10.1016/j.antiviral.2020.104732openalex-snapshot
The direct and indirect consequences of cytomegalovirus infection and potential benefits of vaccination
inferred← citeshttps://doi.org/10.1016/j.antiviral.2020.104957openalex-snapshot
Substitution-inert polynuclear platinum compounds inhibit human cytomegalovirus attachment and entry
inferred← citeshttps://doi.org/10.1016/j.carbpol.2021.118965openalex-snapshot
Chitosan/benzyloxy-benzaldehyde modified ZnO nano template having optimized and distinct antiviral potency to human cytomegalovirus
inferred← citeshttps://doi.org/10.1016/j.clinmicnews.2005.06.001openalex-snapshot
Common viral infections in transplant recipients, part 1. Herpesviruses
inferred← citeshttps://doi.org/10.1016/j.clp.2014.10.006openalex-snapshot
Perinatal Cytomegalovirus and Varicella Zoster Virus Infections
inferred← citeshttps://doi.org/10.1016/j.coviro.2014.02.004openalex-snapshot
Progress on human cytomegalovirus vaccines for prevention of congenital infection and disease
inferred← citeshttps://doi.org/10.1016/j.coviro.2017.02.003openalex-snapshot
Development of a vaccine against cytomegalovirus infection and disease
inferred← citeshttps://doi.org/10.1016/j.ddstr.2006.06.007openalex-snapshot
Why do we not have a vaccine against congenital cytomegalovirus (CMV) infection?
inferred← citeshttps://doi.org/10.1016/j.earlhumdev.2011.08.021openalex-snapshot
Evidence based management guidelines for the detection and treatment of congenital CMV
inferred← citeshttps://doi.org/10.1016/j.ebiom.2015.08.003openalex-snapshot
Prevention of Primary Cytomegalovirus Infection in Pregnancy
inferred← citeshttps://doi.org/10.1016/j.ejps.2020.105279openalex-snapshot
Immuno-informatics approach to design a multi-epitope vaccine to combat cytomegalovirus infection
inferred← citeshttps://doi.org/10.1016/j.gyobfe.2010.07.016openalex-snapshot
La prévention de l’infection maternelle à cytomégalovirus est-elle possible ?
inferred← citeshttps://doi.org/10.1016/j.imlet.2008.07.010openalex-snapshot
A novel approach to evaluate the immunogenicity of viral antigens of clinical importance in HLA transgenic murine models
inferred← citeshttps://doi.org/10.1016/j.jbc.2025.108490openalex-snapshot
Small glycomimetic antagonists of the cytomegalovirus glycoprotein UL141 prevent binding to TRAIL death receptor
inferred← citeshttps://doi.org/10.1016/j.jcv.2005.09.013openalex-snapshot
Breast milk as a source for acquisition of cytomegalovirus (HCMV) in a premature infant with sepsis syndrome: Detection by real-time PCR
inferred← citeshttps://doi.org/10.1016/j.jcv.2005.09.018openalex-snapshot
Attenuated poxvirus expressing three immunodominant CMV antigens as a vaccine strategy for CMV infection
inferred← citeshttps://doi.org/10.1016/j.jcv.2007.10.008openalex-snapshot
Comparison of vaccine strategies against congenital CMV infection in the guinea pig model
inferred← citeshttps://doi.org/10.1016/j.jcv.2009.07.003openalex-snapshot
Ad-gBCMVpoly: A novel chimeric vaccine strategy for human cytomegalovirus-associated diseases
inferred← citeshttps://doi.org/10.1016/j.jcv.2009.08.012openalex-snapshot
Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system
inferred← citeshttps://doi.org/10.1016/j.jiph.2013.08.006openalex-snapshot
Cytomegalovirus seroprevalence in women with bad obstetric history in Kirkuk, Iraq
inferred← citeshttps://doi.org/10.1016/j.jpeds.2007.07.015openalex-snapshot
Prospects for Development and Potential Impact of a Vaccine Against Congenital Cytomegalovirus (CMV) Infection
inferred← citeshttps://doi.org/10.1016/j.jviromet.2016.11.001openalex-snapshot
Establishment and validation of an enzyme-linked immunosorbent assay for IgG antibody against cytomegalovirus based on pp150 antigen
inferred← citeshttps://doi.org/10.1016/j.mad.2015.12.005openalex-snapshot
Suppressive effects of sirtinol on human cytomegalovirus (hCMV) infection and hCMV-induced activation of molecular mechanisms of senescence and production of reactive oxygen species
inferred← citeshttps://doi.org/10.1016/j.mehy.2006.03.026openalex-snapshot
A reformulation of the hygiene hypothesis: Maternal infectious diseases confer protection against asthma in the infant
inferred← citeshttps://doi.org/10.1016/j.micinf.2017.12.010openalex-snapshot
Immune responses to congenital cytomegalovirus infection
inferred← citeshttps://doi.org/10.1016/j.molmed.2005.11.006openalex-snapshot
Human cytomegalovirus vaccine: time to look for alternative options
inferred← citeshttps://doi.org/10.1016/j.ogc.2018.01.006openalex-snapshot
Infections in Pregnancy and the Role of Vaccines
inferred← citeshttps://doi.org/10.1016/j.pcl.2012.12.008openalex-snapshot
Congenital Cytomegalovirus Infection
inferred← citeshttps://doi.org/10.1016/j.semperi.2021.151393openalex-snapshot
Economic assessments of the burden of congenital cytomegalovirus infection and the cost-effectiveness of prevention strategies
inferred← citeshttps://doi.org/10.1016/j.tim.2020.04.003openalex-snapshot
Role of Neutralizing Antibodies in CMV Infection: Implications for New Therapeutic Approaches
inferred← citeshttps://doi.org/10.1016/j.vaccine.2007.08.016openalex-snapshot
Development and preclinical evaluation of an alphavirus replicon particle vaccine for cytomegalovirus
inferred← citeshttps://doi.org/10.1016/j.vaccine.2009.09.135openalex-snapshot
Randomized, double-blind, Phase 1 trial of an alphavirus replicon vaccine for cytomegalovirus in CMV seronegative adult volunteers
inferred← citeshttps://doi.org/10.1016/j.vaccine.2010.06.051openalex-snapshot
Assessment of parental acceptance of a potential cytomegalovirus vaccine for adolescent females
inferred← citeshttps://doi.org/10.1016/j.vaccine.2011.08.086openalex-snapshot
A novel high-throughput neutralization assay for supporting clinical evaluations of human cytomegalovirus vaccines
inferred← citeshttps://doi.org/10.1016/j.vaccine.2011.09.056openalex-snapshot
Quantitative analysis of neutralizing antibody response to human cytomegalovirus in natural infection
inferred← citeshttps://doi.org/10.1016/j.vaccine.2012.04.011openalex-snapshot
Cost-effectiveness of routine vaccination of adolescent females against cytomegalovirus
inferred← citeshttps://doi.org/10.1016/j.vaccine.2012.09.056openalex-snapshot
The next generation recombinant human cytomegalovirus vaccine candidates—Beyond gB
inferred← citeshttps://doi.org/10.1016/j.vaccine.2012.10.053openalex-snapshot
Restoration of viral epithelial tropism improves immunogenicity in rabbits and rhesus macaques for a whole virion vaccine of human cytomegalovirus
inferred← citeshttps://doi.org/10.1016/j.vaccine.2012.10.074openalex-snapshot
Desirability and feasibility of a vaccine against cytomegalovirus
inferred← citeshttps://doi.org/10.1016/j.vaccine.2012.12.009openalex-snapshot
Vectored co-delivery of human cytomegalovirus gH and gL proteins elicits potent complement-independent neutralizing antibodies
inferred← citeshttps://doi.org/10.1016/j.vaccine.2013.08.077openalex-snapshot
Seroprevalences of varicella-zoster virus, herpes simplex virus and cytomegalovirus in a cross-sectional study in Mexico
inferred← citeshttps://doi.org/10.1016/j.vaccine.2013.09.042openalex-snapshot
Priorities for CMV vaccine development
inferred← citeshttps://doi.org/10.1016/j.vaccine.2014.03.057openalex-snapshot
Progress on pursuit of human cytomegalovirus vaccines for prevention of congenital infection and disease
inferred← citeshttps://doi.org/10.1016/j.vaccine.2014.05.014openalex-snapshot
Modeling the potential impact of vaccination on the epidemiology of congenital cytomegalovirus infection
inferred← citeshttps://doi.org/10.1016/j.vaccine.2014.07.030openalex-snapshot
Development of a transmission-blocking malaria vaccine: Progress, challenges, and the path forward
inferred← citeshttps://doi.org/10.1016/j.vaccine.2015.06.019openalex-snapshot
Comparison of monovalent glycoprotein B with bivalent gB/pp65 (GP83) vaccine for congenital cytomegalovirus infection in a guinea pig model: Inclusion of GP83 reduces gB antibody response but both vaccine approaches provide equivalent protection against pup mortality
inferred← citeshttps://doi.org/10.1016/j.vaccine.2018.01.068openalex-snapshot
The National Vaccine Advisory Committee at 30: Impact and opportunity
inferred← citeshttps://doi.org/10.1016/j.vaccine.2018.07.056openalex-snapshot
Novel trimeric human cytomegalovirus glycoprotein B elicits a high-titer neutralizing antibody response
inferred← citeshttps://doi.org/10.1016/j.vaccine.2021.06.033openalex-snapshot
Characterization of gH/gL/pUL128-131 pentameric complex, gH/gL/gO trimeric complex, gB and gM/gN glycoproteins in a human cytomegalovirus using automated capillary western blots
inferred← citeshttps://doi.org/10.1016/j.vaccine.2023.06.003openalex-snapshot
Characterization of epitopes of human monoclonal antibodies against cytomegalovirus glycoprotein B for neutralization and antibody-dependent phagocytosis
inferred← citeshttps://doi.org/10.1016/j.vaccine.2023.06.020openalex-snapshot
Vaccine value profile for cytomegalovirus
inferred← citeshttps://doi.org/10.1016/j.virol.2007.03.002openalex-snapshot
Functional characterization of chimpanzee cytomegalovirus chemokine, vCXCL-1CCMV
inferred← citeshttps://doi.org/10.1016/j.virol.2008.05.002openalex-snapshot
Polymorphisms within human cytomegalovirus chemokine (UL146/UL147) and cytokine receptor genes (UL144) are not predictive of sequelae in congenitally infected children
inferred← citeshttps://doi.org/10.1016/j.virol.2017.06.008openalex-snapshot
Cytomegalovirus UL128 homolog mutants that form a pentameric complex produce virus with impaired epithelial and trophoblast cell tropism and altered pathogenicity in the guinea pig
inferred← citeshttps://doi.org/10.1016/j.virol.2020.06.006openalex-snapshot
Identification of a novel signaling complex containing host chemokine receptor CXCR4, Interleukin-10 receptor, and human cytomegalovirus US27
inferred← citeshttps://doi.org/10.1016/j.virol.2026.110791openalex-snapshot
Characterizing the interactions between murine cytomegalovirus M72 and the carbon catabolite repression 4-negative on TATA-less (CCR4-NOT) complex
inferred← citeshttps://doi.org/10.1016/s0140-6736(11)60136-0openalex-snapshot
Cytomegalovirus glycoprotein-B vaccine with MF59 adjuvant in transplant recipients: a phase 2 randomised placebo-controlled trial
inferred← citeshttps://doi.org/10.1016/s0246-0335(17)61757-5openalex-snapshot
10.1016/s0246-0335(17)61757-5
inferred← citeshttps://doi.org/10.1016/s1473-3099(04)01202-2openalex-snapshot
Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments
inferred← citeshttps://doi.org/10.1016/s1473-3099(11)70367-xopenalex-snapshot
Cytomegalovirus vaccine: light on the horizon
inferred← citeshttps://doi.org/10.1016/s1473-3099(12)70197-4openalex-snapshot
Burden of disease associated with human cytomegalovirus and prospects for elimination by universal immunisation
inferred← citeshttps://doi.org/10.1016/s2055-6640(20)30872-4openalex-snapshot
Cytomegalovirus vaccines under clinical development
inferred← citeshttps://doi.org/10.1017/s0950268813002720openalex-snapshot
A cohort study in university students: investigation of risk factors for cytomegalovirus infection
inferred← citeshttps://doi.org/10.1017/s0950268817000103openalex-snapshot
Seroprevalence of cytomegalovirus infection in France in 2010
inferred← citeshttps://doi.org/10.1017/s1462399408000872openalex-snapshot
Manipulation of dendritic cell functions by human cytomegalovirus
inferred← citeshttps://doi.org/10.1038/cmi.2014.120openalex-snapshot
The immunological underpinnings of vaccinations to prevent cytomegalovirus disease
inferred← citeshttps://doi.org/10.1038/cmi.2014.51openalex-snapshot
Immunobiology of congenital cytomegalovirus infection of the central nervous system—the murine cytomegalovirus model
inferred← citeshttps://doi.org/10.1038/ncomms9176openalex-snapshot
Structure of HCMV glycoprotein B in the postfusion conformation bound to a neutralizing human antibody
inferred← citeshttps://doi.org/10.1038/s41467-023-36683-xopenalex-snapshot
The cytomegalovirus gB/MF59 vaccine candidate induces antibodies against an antigenic domain controlling cell-to-cell spread
inferred← citeshttps://doi.org/10.1038/s41541-017-0038-0openalex-snapshot
Complement enhances in vitro neutralizing potency of antibodies to human cytomegalovirus glycoprotein B (gB) and immune sera induced by gB/MF59 vaccination
inferred← citeshttps://doi.org/10.1038/s41541-017-0042-4openalex-snapshot
Pregnancy and infection: using disease pathogenesis to inform vaccine strategy
inferred← citeshttps://doi.org/10.1038/srep23692openalex-snapshot
Human cytomegalovirus gH stability and trafficking are regulated by ER-associated degradation and transmembrane architecture
inferred← citeshttps://doi.org/10.1042/cs20250044openalex-snapshot
Human cytomegalovirus at the maternal–fetal interface: an overview of pathogenesis, defence, and interventions
inferred← citeshttps://doi.org/10.1044/leader.ftr2.13062008.14openalex-snapshot
Cytomegalovirus: A Major Cause of Hearing Loss in Children
inferred← citeshttps://doi.org/10.1053/j.spid.2004.09.012openalex-snapshot
Antiviral therapy of congenital cytomegalovirus infection
inferred← citeshttps://doi.org/10.1055/s-0032-1333133openalex-snapshot
Cytomegalovirus: Should We Screen Pregnant Women for Primary Infection?
inferred← citeshttps://doi.org/10.1071/ma15068openalex-snapshot
Animal models of human cytomegalovirus congenital infection
inferred← citeshttps://doi.org/10.1073/pnas.1316517110openalex-snapshot
Pentameric complex of viral glycoprotein H is the primary target for potent neutralization by a human cytomegalovirus vaccine
inferred← citeshttps://doi.org/10.1073/pnas.1415310111openalex-snapshot
Antibody-driven design of a human cytomegalovirus gHgLpUL128L subunit vaccine that selectively elicits potent neutralizing antibodies
inferred← citeshttps://doi.org/10.1073/pnas.1424818112openalex-snapshot
Structural and biochemical studies of HCMV gH/gL/gO and Pentamer reveal mutually exclusive cell entry complexes
inferred← citeshttps://doi.org/10.1073/pnas.1800224115openalex-snapshot
Protection from cytomegalovirus viremia following glycoprotein B vaccination is not dependent on neutralizing antibodies
inferred← citeshttps://doi.org/10.1073/pnas.1814835116openalex-snapshot
HCMV trimer- and pentamer-specific antibodies synergize for virus neutralization but do not correlate with congenital transmission
inferred← citeshttps://doi.org/10.1073/pnas.1816933116openalex-snapshot
Human cytomegalovirus G protein-coupled receptor US28 promotes latency by attenuating c-fos
inferred← citeshttps://doi.org/10.1073/pnas.1903317116openalex-snapshot
Neutralization of rhesus cytomegalovirus IL-10 reduces horizontal transmission and alters long-term immunity
inferred← citeshttps://doi.org/10.1073/pnas.2108631118openalex-snapshot
STING facilitates nuclear import of herpesvirus genome during infection
inferred← citeshttps://doi.org/10.1074/jbc.m115.652230openalex-snapshot
Soluble Human Cytomegalovirus gH/gL/pUL128–131 Pentameric Complex, but Not gH/gL, Inhibits Viral Entry to Epithelial Cells and Presents Dominant Native Neutralizing Epitopes
inferred← citeshttps://doi.org/10.1080/00365540802308431openalex-snapshot
Congenital CMV infection: Prevalence in newborns and the impact on hearing deficit
inferred← citeshttps://doi.org/10.1080/21645515.2016.1164376openalex-snapshot
Preclinical evaluations of peptide-conjugate vaccines targeting the antigenic domain-2 of glycoprotein B of human cytomegalovirus
inferred← citeshttps://doi.org/10.1086/507642openalex-snapshot
Editorial Commentary:The Role of the Placenta in the Pathogenesis of Congenital Cytomegalovirus Infection: Is the Benefit of Cytomegalovirus Immune Globulin for the Newborn Mediated through Improved Placental Health and Function?
inferred← citeshttps://doi.org/10.1086/518042openalex-snapshot
Cytomegalovirus (CMV) IE1‐ and pp65‐Specific CD8+T Cell Responses Broaden over Time after Primary CMV Infection in Infants
inferred← citeshttps://doi.org/10.1086/590934openalex-snapshot
Immunocompromised Hosts: Perspectives in the Treatment and Prophylaxis of Cytomegalovirus Disease in Solid‐Organ Transplant Recipients
inferred← citeshttps://doi.org/10.1086/652438openalex-snapshot
Cytomegalovirus Seroprevalence in the United States: The National Health and Nutrition Examination Surveys, 1988–2004
inferred← citeshttps://doi.org/10.1089/jwh.2006.15.224openalex-snapshot
The Epidemiology and Prevention of Congenital Cytomegalovirus Infection and Disease: Activities of the Centers for Disease Control and Prevention Workgroup
inferred← citeshttps://doi.org/10.1089/jwh.2007.0523openalex-snapshot
Women's Knowledge of Congenital Cytomegalovirus: Results From the 2005 HealthStyles™ Survey
inferred← citeshttps://doi.org/10.1089/rej.2006.9.111openalex-snapshot
Immunorejuvenation in the Elderly
inferred← citeshttps://doi.org/10.1093/aje/kwaa240openalex-snapshot
Common Childhood Viruses and Pubertal Timing: The LEGACY Girls Study
inferred← citeshttps://doi.org/10.1093/bmb/ldz031openalex-snapshot
Advances in the treatment of cytomegalovirus
inferred← citeshttps://doi.org/10.1093/cid/ciab084openalex-snapshot
Poor Responses to Pneumococcal Vaccination in CKD Patients—Do We Need to Talk About Cytomegalovirus Again?
inferred← citeshttps://doi.org/10.1093/cid/cit048openalex-snapshot
Complex Correlates of Protection After Vaccination
inferred← citeshttps://doi.org/10.1093/ilar.47.1.49openalex-snapshot
Nonhuman Primate Models of Intrauterine Cytomegalovirus Infection
inferred← citeshttps://doi.org/10.1093/ilar.47.1.65openalex-snapshot
Nonprimate Models of Congenital Cytomegalovirus (CMV) Infection: Gaining Insight into Pathogenesis and Prevention of Disease in Newborns
inferred← citeshttps://doi.org/10.1093/infdis/jir144openalex-snapshot
Could Therapeutic Vaccination of Cytomegalovirus-Seropositive Persons Prevent Reinfection and Congenital Virus Transmission?
inferred← citeshttps://doi.org/10.1093/infdis/jiu568openalex-snapshot
Increasing Complexity of Vaccine Development
inferred← citeshttps://doi.org/10.1093/infdis/jiz402openalex-snapshot
Review of Mathematical Models of Vaccination for Preventing Congenital Cytomegalovirus Infection
inferred← citeshttps://doi.org/10.1093/infdis/jiz493openalex-snapshot
Advances in the Development of Therapeutics for Cytomegalovirus Infections
inferred← citeshttps://doi.org/10.1093/jbmr/zjag016openalex-snapshot
Adding to the cytomegalovirus crime sheet? Editorial on “Osteonecrosis of the femoral head is associated with cytomegalovirus reactivation”
inferred← citeshttps://doi.org/10.1093/pch/19.1.e1openalex-snapshot
Congenital cytomegalovirus infection in Canada: Active surveillance for cases diagnosed by paediatricians
inferred← citeshttps://doi.org/10.1097/01.inf.0000199261.98769.29openalex-snapshot
Multicity Italian Study of Congenital Cytomegalovirus Infection
inferred← citeshttps://doi.org/10.1097/01.mop.0000193285.71775.ebopenalex-snapshot
Current World Literature
inferred← citeshttps://doi.org/10.1097/01.naj.0000393056.01687.40openalex-snapshot
Occupational Hazards for Pregnant Nurses
inferred← citeshttps://doi.org/10.1097/01.tp.0000280537.53500.29openalex-snapshot
Cytomegalovirus Prevention: Prophylaxis and Preemptive Therapy
inferred← citeshttps://doi.org/10.1097/grf.0b013e3182510b7bopenalex-snapshot
Prevention of Maternal and Congenital Cytomegalovirus Infection
inferred← citeshttps://doi.org/10.1097/inf.0000000000001407openalex-snapshot
Symptomatic Cytomegalovirus Infections in the First Year of Life
inferred← citeshttps://doi.org/10.1097/inf.0000000000002808openalex-snapshot
Prevalence and Clinical Manifestations of Congenital Cytomegalovirus Infection in a Screening Program in Madrid (PICCSA Study)
inferred← citeshttps://doi.org/10.1097/moo.0000000000000104openalex-snapshot
Congenital cytomegalovirus
inferred← citeshttps://doi.org/10.1097/qco.0b013e32818be70aopenalex-snapshot
Advances in pathogenesis and management of sepsis
inferred← citeshttps://doi.org/10.1097/qco.0b013e328236742eopenalex-snapshot
Late-onset cytomegalovirus disease in patients with solid organ transplant
inferred← citeshttps://doi.org/10.1099/acmi.0.000147openalex-snapshot
Lessons from studies with murine cytomegalovirus that could lead to a safe live attenuated vaccine for human cytomegalovirus
inferred← citeshttps://doi.org/10.1099/jgv.0.000603openalex-snapshot
A little cooperation helps murine cytomegalovirus (MCMV) go a long way: MCMV co-infection rescues a chemokine salivary gland defect
inferred← citeshttps://doi.org/10.1099/jgv.0.000882openalex-snapshot
The pentameric complex of human Cytomegalovirus: cell tropism, virus dissemination, immune response and vaccine development
inferred← citeshttps://doi.org/10.1099/jgv.0.001860openalex-snapshot
A temperature-dependent virus-binding assay reveals the presence of neutralizing antibodies in human cytomegalovirus gB vaccine recipients’ sera
inferred← citeshttps://doi.org/10.1099/jgv.0.002248openalex-snapshot
Decoding the antiviral potential of eugenol, thymol and vanillin against human cytomegalovirus infection
inferred← citeshttps://doi.org/10.1099/vir.0.029413-0openalex-snapshot
Recombinant glycoprotein B vaccine formulation with Toll-like receptor 9 agonist and immune-stimulating complex induces specific immunity against multiple strains of cytomegalovirus
inferred← citeshttps://doi.org/10.1099/vir.0.81891-0openalex-snapshot
Latency and reactivation of human cytomegalovirus
inferred← citeshttps://doi.org/10.1101/2020.12.31.424954openalex-snapshot
Intermittent Bulk Release of Human Cytomegalovirus
inferred← citeshttps://doi.org/10.1111/cei.12297openalex-snapshot
Cytomegalovirus drives Vδ2neg γδ T cell inflation in many healthy virus carriers with increasing age
inferred← citeshttps://doi.org/10.1111/j.1365-2648.2008.04726.xopenalex-snapshot
Hygiene interventions for prevention of cytomegalovirus infection among childbearing women: systematic review
inferred← citeshttps://doi.org/10.1111/j.1600-0757.2009.00325.xopenalex-snapshot
Human viruses in periodontitis
inferred← citeshttps://doi.org/10.1111/jicd.12029openalex-snapshot
Viruses: are they really culprits for periodontal disease? A critical review
inferred← citeshttps://doi.org/10.1111/tid.70329openalex-snapshot
Cytomegalovirus Vaccines in Transplantation: History, Hurdles, and Hope
inferred← citeshttps://doi.org/10.1126/sciimmunol.aan1457openalex-snapshot
Structural basis for potent antibody-mediated neutralization of human cytomegalovirus
inferred← citeshttps://doi.org/10.1126/scitranslmed.aaf9387openalex-snapshot
A replication-defective human cytomegalovirus vaccine for prevention of congenital infection
inferred← citeshttps://doi.org/10.1128/9781555817411.ch16openalex-snapshot
Immunotherapeutic Approaches To Prevent Cytomegalovirus-Mediated Disease
inferred← citeshttps://doi.org/10.1128/aem.03262-13openalex-snapshot
Cytomegalovirus Survival and Transferability and the Effectiveness of Common Hand-Washing Agents against Cytomegalovirus on Live Human Hands
inferred← citeshttps://doi.org/10.1128/cmr.00062-12openalex-snapshot
The “Silent” Global Burden of Congenital Cytomegalovirus
inferred← citeshttps://doi.org/10.1128/cvi.00300-16openalex-snapshot
Additive Protection against Congenital Cytomegalovirus Conferred by Combined Glycoprotein B/pp65 Vaccination Using a Lymphocytic Choriomeningitis Virus Vector
inferred← citeshttps://doi.org/10.1128/cvi.00491-16openalex-snapshot
Congenital Cytomegalovirus: a “Now” Problem—No Really, Now
inferred← citeshttps://doi.org/10.1128/cvi.05128-11openalex-snapshot
Neutralizing Activity of Saliva against Cytomegalovirus
inferred← citeshttps://doi.org/10.1128/jcm.01670-06openalex-snapshot
Epidemiologic Analysis of Reactivated Cytomegalovirus Antigenemia in Patients with Cancer
inferred← citeshttps://doi.org/10.1128/jvi.00030-18openalex-snapshot
Advancing Our Understanding of Protective Maternal Immunity as a Guide for Development of Vaccines To Reduce Congenital Cytomegalovirus Infections
inferred← citeshttps://doi.org/10.1128/jvi.00121-16openalex-snapshot
Monoclonal Antibodies to Different Components of the Human Cytomegalovirus (HCMV) Pentamer gH/gL/pUL128L and Trimer gH/gL/gO as well as Antibodies Elicited during Primary HCMV Infection Prevent Epithelial Cell Syncytium Formation
inferred← citeshttps://doi.org/10.1128/jvi.00207-25openalex-snapshot
Replication-deficient whole-virus vaccines against cytomegalovirus induce protective immunity in a guinea pig congenital infection model
inferred← citeshttps://doi.org/10.1128/jvi.00213-24openalex-snapshot
A broadly neutralizing human monoclonal antibody generated from transgenic mice immunized with HCMV particles limits virus infection and proliferation
inferred← citeshttps://doi.org/10.1128/jvi.00275-06openalex-snapshot
Experimental Confirmation of Global Murine Cytomegalovirus Open Reading Frames by Transcriptional Detection and Partial Characterization of Newly Described Gene Products
inferred← citeshttps://doi.org/10.1128/jvi.00320-16openalex-snapshot
Repair of a Mutation Disrupting the Guinea Pig Cytomegalovirus Pentameric Complex Acquired during Fibroblast Passage Restores Pathogenesis in Immune-Suppressed Guinea Pigs and in the Context of Congenital Infection
showing the first 200 of 323 · page through all 323
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.